Table 3.

Frequently reported adverse events.

	BK-SE36 IM		BK-SE36 SC		Control
	Cohort 1	Cohort 2	Cohort 1	Cohort 2	Cohort 1	Cohort 2
	n = 18	n = 18	n = 18	n = 18	n = 18	n = 18
Bronchitis	11 (61%)* [19]	13 (72%) [39]	14 (78%) [26]	15 (83%) [41]	10 (56%) [20]	13 (72%) [29]
Rhinitis	11 (61%) [15]	13 (72%) [39]	10 (56%) [18]	16 (89%) [39]	11 (61%) [20]	14 (78%) [33]
Cough	4 (22%) [6]	0	3 (17%) [4]	3 (17%) [3]	3 (17%) [4]	0
Enteritis	0	9 (50%) [14]	0	7 (39%) [13]	2 (11%) [2]	7 (39%) [11]
Gastroenteritis	0	2 (11%) [2]	0	3 (17%) [3]	0	4 (22%) [4]

*no. of children experiencing an event (% of children), [total no. of events]